Coremed, Inc. Introduces IVE(TM), A Proprietary Drug-Delivery Platform Technology That Improves Protein Absorption Within The Gastrointestinal Tract
11/14/2005 1:06:00 PM
More...
|
Coremed, Inc. To Raise Funds And Structure Strategic Alliances For Developing Inhalable And Oral Insulin-Delivery Systems
10/19/2005 5:11:35 PM
More...
|
Coremed, Inc. Announces Major Breakthrough In Development Of Alvair(TM), Pulmonary-Delivered Insulin, Based On Animal Study
10/19/2005 5:10:15 PM
More...
|
Based On Pre-Clinical Data, Coremed, Inc.'s Alveair Insulin(TM) Achieves Better Insulin Bioavailability Than Intravenous Injection Of Analog Insulin
10/19/2005 5:09:56 PM
More...
|
Coremed, Inc., Announces Positive Data From First Human Trial Of Alveair(TM) Insulin Pulmonary Technology
10/19/2005 5:09:43 PM
More...
|
Coremed, Inc. To Announce Human Trials Of Alveair(TM) Insulin Pulmonary Technology That Performs Like A "Needle-Less Syringe"
10/19/2005 5:09:35 PM
More...
|
Coremed, Inc. Signs Joint Venture With China's Major Pharmas To Develop Alveair(TM) Inhalable Insulin
10/19/2005 5:09:10 PM
More...
|